ABVX vs ALKS: stock comparison and AI forecast
Abivax S.A. (ABVX) and Alkermes Plc. (ALKS) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market
Share
ABVX Abivax S.A.
- Price
- $88.71 -28.3% · 6M
- Market Cap
- $6.97B
- P/E Ratio
- –
- Size
- mid-cap
- AI Forecast
ALKS Alkermes Plc.
- Price
- $45.89 +29.9% · 6M
- Market Cap
- $7.70B
- P/E Ratio
- 44.6x
- Size
- mid-cap
- AI Forecast
Which one does the AI model favor?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
Six-month price performance
Closing prices rebased to 100 at the start of the window.
Key facts
- ALKS is 1.1 times larger than ABVX by market capitalization ($7.70B against $6.97B).
- Over the last six months ALKS returned +29.9% and ABVX -28.3%.
- Both companies share the SEC industry classification Pharmaceutical Preparations.
Fundamentals side by side
Trailing twelve months.
Valuation & Market
| Metric | ABVX | ALKS |
|---|---|---|
| Market Cap | $6.97B | $7.70B |
| P/E Ratio | – | 44.55x |
| P/B Ratio | – | 4.13x |
| EPS | $-9.65 | $1.03 |
| Book Value/Share | – | $11.12 |
| Revenue/Share | – | $10.45 |
| FCF/Share | $-5.76 | $1.36 |
Profitability & Margins
| Metric | ABVX | ALKS |
|---|---|---|
| ROE | -129.7% | -0.0% |
| ROA | -101.0% | -0.0% |
| ROIC | -80.7% | 1.7% |
| Gross Margin | – | 82.9% |
| Operating Margin | – | 3.7% |
| Net Margin | – | -0.0% |
| EBT Margin | – | 0.7% |
| Tax Rate | -1.0% | 103.1% |
Financial Health
| Metric | ABVX | ALKS |
|---|---|---|
| Current Ratio | 8.75x | 2.42x |
| Quick Ratio | – | 2.02x |
| D/E Ratio | – | 1.38x |
| Financial Leverage | 1.28x | 2.38x |
| Interest Coverage | – | 14.7x |
| Working Capital | $574M | $929M |
Cash Flow
| Metric | ABVX | ALKS |
|---|---|---|
| Operating Cash Flow | -$452M | $243M |
| Free Cash Flow | -$452M | $227M |
| Capital Spending | -$340K | -$16M |
| OCF Growth YoY | – | -55.1% |
| FCF Growth YoY | – | -53.7% |
| FCF/Sales | – | 13.0% |
| CapEx/Sales | – | 0.9% |
Operational Efficiency
| Metric | ABVX | ALKS |
|---|---|---|
| Asset Turnover | – | 0.40x |
| Receivables Turnover | – | 3.8x |
| Inventory Turnover | – | 1.1x |
| Fixed Assets Turnover | – | 8.2x |
| Days Sales Outstanding | – | 96 days |
| Days Inventory | – | 318 days |
| Payables Period | – | 131 days |
| Cash Conversion Cycle | – | 282 days |
Income Statement
| Metric | ABVX | ALKS |
|---|---|---|
| Total Revenue | – | $1.75B |
| Operating Income | -$476M | $64M |
| Net Income | -$669M | -$350K |
| R&D Expense | $353M | $430M |
| SG&A Expense | – | $878M |
| Cost of Goods Sold | – | $300M |
Dividend & Shareholder Information
| Metric | ABVX | ALKS |
|---|---|---|
| Shares Outstanding | 79M | 168M |
| Net Income Growth | – | -100.1% |
| EPS Growth | – | -51.2% |
ABVX vs ALKS: stock comparison and AI forecast
Which is bigger, ABVX or ALKS?
ALKS is 1.1 times larger than ABVX by market capitalization ($7.70B against $6.97B).
Which stock performed better over the last six months, ABVX or ALKS?
Over the last six months ALKS returned +29.9% and ABVX -28.3%.
Which one does Intratio's AI model rank higher, ABVX or ALKS?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
More comparisons
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.